Please assess the completion status of the following clinical trial:

Trial Title: Zero Sodium Peritoneal Dialysate Protocol Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients actively undergoing peritoneal dialysis (PD) with a functioning PD catheter~2. PD vintage \< 3 years~3. As judged by treating nephrologist to be at or above optimal volume status (i.e., not dehydrated)~Exclusion Criteria:~1. Uncontrolled diabetes with frequent episodes of severe hyperglycemia~2. Systolic blood pressure \< 100 mmHg~3. Serum sodium \< 130 mEq/L~4. 1 or more episodes of peritonitis in the previous 6 months or active infection of the peritoneal dialysis catheter~5. Anemia with hemoglobin \<8 g/dL~6. Serum bicarbinate \< 18 mEq/L~7. Anuric renal failure~8. Inability to give written informed consent or follow study protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 10% dextrose in sterile water (Type: EXPERIMENTAL): Patients randomized to this arm will undergo a two-hour dwell with 10% dextrose in sterile water at their first visit and Dianeal Low-Calcium with 4.25% Dextrose at their second visit.
- Dianeal Low-Calcium with 4.25% Dextrose (Type: ACTIVE_COMPARATOR): Patients randomized to this arm will undergo a two-hour dwell with Dianeal Low-Calcium with 4.25% Dextrose at their first visit and 10% dextrose in sterile water at their second visit.

Based on this trial design, predict the completion outcome and termination type (if applicable).